Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of genotypic resistance testing on selection of salvage regimen in clinical practice.

Antiviral therapy - 1 Oct 2003

Haupts Stefan, Ledergerber Bruno, Böni Jörg, Schüpbach Jörg, Kronenberg Andreas, Opravil Milos, Flepp Markus, Speck Roberto F, Grube Christina, Rentsch Katharina, Weber Rainer, Günthard Huldrych F

Abstract excerpt

OBJECTIVE: To determine whether genotypic resistance testing leads to selection of more potent drug regimens when compared to regimens based on treatment history only. DESIGN: Prospective, tertiary care centre-based study. PATIENTS: One-hundred-and-forty-five HIV-infected adults on stable antiretroviral therapy (ART) for >6 months experiencing virological failure. METHODS: The physicians' decision-making process...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Therapy, Combination

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Protease

Share to HIV Reverse Transcriptase

Share to Practice Patterns, Physicians'

Share to Reverse Transcriptase Inhibitors

Share to Salvage Therapy

Share to Viral Load

Source

Identifiers

PMID: 14640392

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of genotypic resistance testing on selection of salvage regimen in clinical practice.PMID 14640392Read ↗

HIV-1 resistance testing influences treatment decision-making.Semantic proximity Read ↗

Computer-Aided Optimization of Combined Anti-Retroviral Therapy for HIV: New Drugs, New Drug Targets and Drug Resistance.Semantic proximity Read ↗

A genotypic drug resistance interpretation algorithm that significantly predicts therapy response in HIV-1-infected patients.Semantic proximity Read ↗

Net benefits of resistance testing directed therapy compared with standard of care in HIV-infected patients with virological failure: A meta-analysis.Semantic proximity Read ↗

Comparison of HIV-1 genotypic resistance test interpretation systems in predicting virological outcomes over time.Semantic proximity Read ↗

A comparison of computational models with and without genotyping for prediction of response to second-line HIV therapy.Semantic proximity Read ↗

International perspectives on antiretroviral resistance. Clinical utility of resistance testing: retrospective and prospective data supporting use and current recommendations.Semantic proximity Read ↗

Predictive value of HIV-1 genotypic resistance test interpretation algorithms.Semantic proximity Read ↗

The effect of number of mutations and of drug-class sparing on virological response to salvage genotype-guided antiretroviral therapy.Semantic proximity Read ↗

Computational models can predict response to HIV therapy without a genotype and may reduce treatment failure in different resource-limited settingsSemantic proximity Read ↗

Impact of genotypic resistance testing on physician selection of antiretroviral therapy.Semantic proximity Read ↗

Interpreting resistance data for HIV-1 therapy management--know the limitations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.